199 related articles for article (PubMed ID: 15660460)
1. Analyzing synovial tissue samples. What can we learn about early rheumatoid arthritis, the heterogeneity of the disease, and the effects of treatment?
Tak PP
J Rheumatol Suppl; 2005 Jan; 72():25-6. PubMed ID: 15660460
[TBL] [Abstract][Full Text] [Related]
2. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.
Haringman JJ; Gerlag DM; Zwinderman AH; Smeets TJ; Kraan MC; Baeten D; McInnes IB; Bresnihan B; Tak PP
Ann Rheum Dis; 2005 Jun; 64(6):834-8. PubMed ID: 15576415
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
Gerlag DM; Tak PP
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
[TBL] [Abstract][Full Text] [Related]
4. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
[TBL] [Abstract][Full Text] [Related]
5. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP
Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
[TBL] [Abstract][Full Text] [Related]
7. Effects of infliximab treatment on rheumatoid synovial tissue.
Tak PP
J Rheumatol Suppl; 2005 Mar; 74():31-4. PubMed ID: 15742462
[TBL] [Abstract][Full Text] [Related]
8. [Repair of bone and articular destruction in rheumatoid arthritis].
Kanbe K
Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine in rheumatoid arthritis: a review to date.
Murphy G; Caplice N; Molloy M
Rheumatology (Oxford); 2008 Oct; 47(10):1446-51. PubMed ID: 18495821
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
12. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.
Vos K; Thurlings RM; Wijbrandts CA; van Schaardenburg D; Gerlag DM; Tak PP
Arthritis Rheum; 2007 Mar; 56(3):772-8. PubMed ID: 17328049
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
14. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
Bresnihan B; Pontifex E; Thurlings RM; Vinkenoog M; El-Gabalawy H; Fearon U; Fitzgerald O; Gerlag DM; Rooney T; van de Sande MG; Veale D; Vos K; Tak PP
J Rheumatol; 2009 Aug; 36(8):1800-2. PubMed ID: 19671815
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis.
De Rycke L; Baeten D; Foell D; Kruithof E; Veys EM; Roth J; De Keyser F
J Pathol; 2005 May; 206(1):17-27. PubMed ID: 15809977
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-naïve patients.
Singh JA; Pando JA; Tomaszewski J; Schumacher HR
J Rheumatol; 2004 Jul; 31(7):1281-5. PubMed ID: 15229944
[TBL] [Abstract][Full Text] [Related]
17. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
19. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
20. Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens.
Tsubaki T; Arita N; Kawakami T; Shiratsuchi T; Yamamoto H; Takubo N; Yamada K; Nakata S; Yamamoto S; Nose M
Arthritis Res Ther; 2005; 7(4):R825-36. PubMed ID: 15987484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
